Transcriptional Profiling Of Human Peripheral Blood Mononuclear Cells Exposed To Bacillus Anthracis In Vitro | 9439
Journal of Marine Science: Research & Development
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Dependable and efficient diagnosis of
(BA) has long been a major concern for the care givers. Nonspecific
symptoms during early illness often misguide the diagnosis; thereby jeopardize the proper therapeutic intervention. It is,
therefore, crucial to understand the initial events that take place in a host soon after the onset of infection. The present study
examines the PBMCs challenged by the BA spores in vitro and subsequently cultured the cells for 2 hrs, 4 hrs, 6 hrs, 8 hrs and 24
hrs, respectively. We observe rapid transcriptomic elevation of a number of cytokines, chemokines and other uptake receptors
concurrently with the infection onset. Delayed responses to the BA induced assault include gradual attenuation of the genes linked
with pathogenic uptake, such as MyD88 and TLR4 putatively driving the host towards greater vulnerability. The signs of altering
host defenses nevertheless are evident immediately after the exposure to the BA spores. The pathogenic insult selectively induces
some of the key transcriptomic candidates of apoptotic pathways regulated by the toll-like receptors and the caspase cascade;
and suppresses the transcripts related to the p38 MAPK-dependent pathways. The T-cell receptors and CD3-mediated antigenic
recognition processes are possibly restrained. In conclusion, BA challenges both innate and adaptive immunity processes and
their key interfaces during the early course of infection. We identified a host of early targets across the networks and pathways
primarily related to chemotaxis and apoptosis of immune cells that can potentially facilitate next generation anthrax prevention
is the Director, Integrative Systems Biology and Chief Scientist, Systems Biology Enterprise USAMEDCOM, USACEHR. Jett has more
than 20 years research leading several key research DOD project as the principal investigator.
is the Deputy Director, Integrative Systems Biology, USACEHR. Hammamieh received PhD from Gergetown university and
worked as a senior scientist at WRAIR.
has more than twelve years of experience working in the Biotech industry. He received MS degrees from IIT, Kanpur, India
and UMD, College Park.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals